Your browser doesn't support javascript.
loading
Randomised clinical trial: Design of the SYNERGY-NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction-associated steatohepatitis and modification of screening strategy to reduce screen failures.
Vuppalanchi, Raj; Loomba, Rohit; Sanyal, Arun J; Nikooie, Amir; Tang, Yuanyuan; Robins, Deborah A; Brouwers, Bram; Hartman, Mark L.
Afiliação
  • Vuppalanchi R; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Loomba R; MASLD Research Center, Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA.
  • Sanyal AJ; Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Nikooie A; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Tang Y; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Robins DA; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Brouwers B; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Hartman ML; Eli Lilly and Company, Indianapolis, Indiana, USA.
Aliment Pharmacol Ther ; 60(1): 17-32, 2024 07.
Article em En | MEDLINE | ID: mdl-38768298
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Idioma: En Ano de publicação: 2024 Tipo de documento: Article